title: Psoriasis, lymphoma and etanercept: is there a correlation?
abstract: Psoriasis is a chronic inflammatory disease that can affect skin and joints. Their treatment varies depending on the severity and includes topical and systemic. Among the latter are the immunobiological that target the T cell We report a case that demonstrates the close relationship between psoriasis, lymphoma and biologic therapies.
authors.affiliation: Dermatology Service, Teaching Hospital Pedro Ernesto, State University of Rio de Janeiro, Brazil. ludqmiranda@hotmail.com
authors.forename: Ludmilla Queirós
authors.initials: LQ
authors.lastname: Miranda
authors.forename: Aline Lopes
authors.initials: AL
authors.lastname: Bressan
authors.forename: Fernanda Valente da Silva
authors.initials: FV
authors.lastname: Rehfeldt
authors.forename: Bárbara Nader
authors.initials: BN
authors.lastname: Vasconcelos
authors.forename: Alexandre Carlos
authors.initials: AC
authors.lastname: Gripp
mesh_terms: D000328:Adult; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008223:Lymphoma / Q000209:etiology*; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor; D012878:Skin Neoplasms / Q000209:etiology
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept